| FDA | U.S. Food and Drug Administration |
| CNS | Central nervous system |
| IC50 | Half-maximal inhibitory concentration |
| LD50 | Median lethal dose |
| MIC | Minimum inhibitory concentration |
| MCC | Minimum cytotoxic concentration |
| PET | Positron emission tomography |
| DNA | Deoxyribonucleic acid |
| HIV | Human immunodeficiency virus |
| DDQ | 2,3-Dichloro-5,6-dicyanobenzoquinone |
| CDI | 1,1′-Carbonyldiimidazole |
| 4-NPO | 4-Nitropyridine-N-oxide |
| AgNPs | Silver nanoparticles |
| JAK2 | Janus kinase 2 |
| GSK3 | Glycogen synthase kinase 3 |
| SSAO | Semicarbazide-sensitive amine oxidase |
| cGMP PDE | Cyclic guanosine monophosphate-specific phosphodiesterase type 5 |
| NEU3 | Neuraminidase 3 |
| MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 |
| VZV | Varicella zoster virus |
| DCC | N,N′-Dicyclohexylcarbodiimide |
| SIK | Salt-inducible kinase |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.